Jonatan D. Lindh

4.4k total citations · 1 hit paper
83 papers, 2.9k citations indexed

About

Jonatan D. Lindh is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Pharmacology. According to data from OpenAlex, Jonatan D. Lindh has authored 83 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 25 papers in Endocrinology, Diabetes and Metabolism and 22 papers in Pharmacology. Recurrent topics in Jonatan D. Lindh's work include Electrolyte and hormonal disorders (23 papers), Pharmacogenetics and Drug Metabolism (22 papers) and Hormonal Regulation and Hypertension (19 papers). Jonatan D. Lindh is often cited by papers focused on Electrolyte and hormonal disorders (23 papers), Pharmacogenetics and Drug Metabolism (22 papers) and Hormonal Regulation and Hypertension (19 papers). Jonatan D. Lindh collaborates with scholars based in Sweden, United Kingdom and Norway. Jonatan D. Lindh's co-authors include Anders Rane, Linda Björkhem‐Bergman, Lennart Holm, Peter Bergman, Marine L. Andersson, Buster Mannheimer, Mia Wadelius, Panos Deloukas, Åsa Lindh and Niclas Eriksson and has published in prestigious journals such as Blood, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Jonatan D. Lindh

78 papers receiving 2.8k citations

Hit Papers

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, ... 2009 2026 2014 2020 2009 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonatan D. Lindh Sweden 26 1.3k 556 419 405 368 83 2.9k
Vincent Pichette Canada 39 834 0.7× 301 0.5× 392 0.9× 272 0.7× 697 1.9× 106 4.4k
Ute I. Schwarz Canada 37 2.0k 1.6× 588 1.1× 863 2.1× 255 0.6× 315 0.9× 87 5.6k
Thomas D. Nolin United States 39 664 0.5× 284 0.5× 640 1.5× 196 0.5× 405 1.1× 135 4.3k
Raj Vuppalanchi United States 47 1.2k 1.0× 1.6k 2.9× 478 1.1× 564 1.4× 215 0.6× 180 7.1k
George K. Dresser Canada 28 1.4k 1.1× 334 0.6× 436 1.0× 80 0.2× 139 0.4× 59 3.9k
Loes E. Visser Netherlands 36 872 0.7× 775 1.4× 690 1.6× 75 0.2× 430 1.2× 124 4.3k
Yvonne S. Lin United States 32 1.9k 1.5× 385 0.7× 99 0.2× 326 0.8× 141 0.4× 65 4.0k
C. Michael Stein United States 36 1.6k 1.2× 720 1.3× 2.1k 5.1× 209 0.5× 281 0.8× 68 7.0k
Roberto Padrini Italy 27 646 0.5× 275 0.5× 503 1.2× 171 0.4× 203 0.6× 104 2.7k
Ichiro Ieiri Japan 45 2.1k 1.7× 601 1.1× 237 0.6× 121 0.3× 266 0.7× 176 6.4k

Countries citing papers authored by Jonatan D. Lindh

Since Specialization
Citations

This map shows the geographic impact of Jonatan D. Lindh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonatan D. Lindh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonatan D. Lindh more than expected).

Fields of papers citing papers by Jonatan D. Lindh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonatan D. Lindh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonatan D. Lindh. The network helps show where Jonatan D. Lindh may publish in the future.

Co-authorship network of co-authors of Jonatan D. Lindh

This figure shows the co-authorship network connecting the top 25 collaborators of Jonatan D. Lindh. A scholar is included among the top collaborators of Jonatan D. Lindh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonatan D. Lindh. Jonatan D. Lindh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Calissendorff, Jan, et al.. (2025). Adrenal Tumors in Children and Adolescents in Sweden: A Register-Based Study Covering 15 Years. Journal of the Endocrine Society. 9(5). bvaf058–bvaf058.
2.
Mannheimer, Buster, et al.. (2025). Mortality and causes of death in patients hospitalized with hyponatremia – a propensity matched cohort study. European Journal of Internal Medicine. 138. 76–82. 2 indexed citations
3.
Lindh, Jonatan D., et al.. (2025). Validation of ICD-10 codes used to identify the main reason for hospitalization due to hyponatremia in Sweden. PLoS ONE. 20(2). e0318927–e0318927. 1 indexed citations
5.
Patrova, Jekaterina, Buster Mannheimer, Jonatan D. Lindh, & Henrik Falhammar. (2023). Mortality in Patients With Nonfunctional Adrenal Tumors. JAMA Internal Medicine. 183(8). 832–832. 16 indexed citations
6.
Lindh, Jonatan D., Jekaterina Patrova, R. Louise Rushworth, Buster Mannheimer, & Henrik Falhammar. (2023). Tuberculosis of Adrenal Glands—A Population-based Case-control Study. Journal of the Endocrine Society. 7(5). bvad047–bvad047. 6 indexed citations
7.
Patrova, Jekaterina, et al.. (2022). Congenital adrenal hyperplasia in patients with adrenal tumors: a population-based case–control study. Journal of Endocrinological Investigation. 46(3). 559–565. 12 indexed citations
8.
Mannheimer, Buster, Jakob Skov, Henrik Falhammar, et al.. (2019). Sex-specific risks of death in patients hospitalized for hyponatremia: a population-based study. Endocrine. 66(3). 660–665. 14 indexed citations
9.
Falhammar, Henrik, Jan Calissendorff, Jakob Skov, et al.. (2019). Tramadol- and codeine-induced severe hyponatremia: A Swedish population-based case-control study. European Journal of Internal Medicine. 69. 20–24. 23 indexed citations
10.
Falhammar, Henrik, Jonatan D. Lindh, Jan Calissendorff, et al.. (2018). Antipsychotics and severe hyponatremia: A Swedish population–based case–control study. European Journal of Internal Medicine. 60. 71–77. 32 indexed citations
11.
Holm, Johan, Jonatan D. Lindh, Marine L. Andersson, & Buster Mannheimer. (2017). The effect of amiodarone on warfarin anticoagulation: a register‐based nationwide cohort study involving the Swedish population. Journal of Thrombosis and Haemostasis. 15(3). 446–453. 23 indexed citations
12.
Mannheimer, Buster, Marine L. Andersson, Hans Järnbert‐Pettersson, & Jonatan D. Lindh. (2016). The effect of carbamazepine on warfarin anticoagulation: a register‐based nationwide cohort study involving the Swedish population. Journal of Thrombosis and Haemostasis. 14(4). 765–771. 28 indexed citations
13.
Lindh, Jonatan D., Marine L. Andersson, & Buster Mannheimer. (2014). Adherence to Guidelines for Avoiding Drug Interactions Associated with Warfarin - A Nationwide Swedish Register Study. PLoS ONE. 9(5). e97388–e97388. 10 indexed citations
14.
Chang, Ming, Gunnel Tybring, Marja­‐Liisa Dahl, & Jonatan D. Lindh. (2014). Impact of Cytochrome P450 2C19 Polymorphisms on Citalopram/Escitalopram Exposure: A Systematic Review and Meta-Analysis. Clinical Pharmacokinetics. 53(9). 801–811. 61 indexed citations
15.
Lindh, Jonatan D., Linda Björkhem‐Bergman, & Erik Eliasson. (2012). Vitamin D and drug-metabolising enzymes. Photochemical & Photobiological Sciences. 11(12). 1797–1801. 18 indexed citations
16.
Takeuchi, Fumihiko, Ralph McGinnis, Stéphane Bourgeois, et al.. (2009). A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose. PLoS Genetics. 5(3). e1000433–e1000433. 475 indexed citations breakdown →
17.
Wadelius, Mia, Jonatan D. Lindh, Niclas Eriksson, et al.. (2008). The largest prospective warfarin-treated cohort supports genetic forecasting. Blood. 113(4). 784–792. 413 indexed citations
18.
Lindh, Jonatan D., Lennart Holm, Marja­‐Liisa Dahl, Lars Alfredsson, & Anders Rane. (2007). Incidence and predictors of severe bleeding during warfarin treatment. Journal of Thrombosis and Thrombolysis. 25(2). 151–159. 56 indexed citations
19.
Lindh, Jonatan D., et al.. (2005). Several-fold increase in risk of overanticoagulation by CYP2C9 mutations. Clinical Pharmacology & Therapeutics. 78(5). 540–550. 61 indexed citations
20.
Lindh, Jonatan D., Anita Annas, Lennart Meurling, Marja­‐Liisa Dahl, & Ayman Al‐Shurbaji. (2003). Effect of ketoconazole on venlafaxine plasma concentrations in extensive and poor metabolisers of debrisoquine. European Journal of Clinical Pharmacology. 59(5-6). 401–406. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026